FDA NDC Directory · JSON-LD · Markdown

Maxitrol

NDC 82667-100 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameneomycin sulfate, polymyxin b sulfate and dexamethasone
Labeler / ManufacturerHarrow Eye, LLC
Marketing categoryNew Drug Application (innovator) · App NDA050023
Dosage form / routeSUSPENSION · OPHTHALMIC
Active ingredientsDEXAMETHASONE (1 mg/mL)
NEOMYCIN SULFATE (3.5 mg/mL)
POLYMYXIN B SULFATE (10000 [USP'U]/mL)
Marketing started19641115
Package count1

External sources

Source: openFDA. Public-domain (CC0).